Biodefense Market Size & Share 2022 to 2028
Market Size by Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays and Reagents}) & Forecast.
Report ID: GMI714
|
Published Date: April 2022
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Biodefense Market Size
Biodefense Market size surpassed USD 15.6 billion in 2021 and is expected to witness an 8.7% CAGR from 2022 to 2028 owing to the government-led several safety measures and stock vaccines to protect the economy from damages caused by bioterrorism attacks in developed countries.
Bioterrorism refers to the deliberate release of viruses, bacteria, and other hazardous germs with the potential to spread epidemics and cause death. This condition has a negative impact on the economy because it is harmful to human health and depletes human resources. As a result, governments in developed countries undertake a variety of efforts as well as preventative measures in order to withstand these attacks. Vaccines and biothreat detection technologies are frequently stocked by the government to ensure the safety of the population. Government initiatives like this will help to accelerate the biodefense market share.
The COVID-19 pandemic had a favorable influence on the biodefense market. The COVID-19 pandemic demonstrates how catastrophic biological events may result in significant human and economic loss, necessitating a nationwide response from numerous government and nonfederal agencies. There are several reasons to believe that the COVID-19 pandemic is an intentional act of bioterrorism. COVID-19 promises a huge potential for investment and income redistribution, similar to the swine flu epidemic of 2008-2009, when billions were created by major companies across the globe.
Bio-defenses is a combination of various processes and systems put in place by customs agents, bioscience laboratories, and other professionals to prevent the use of dangerous pathogens and toxins. Biodefense uses medical procedures to protect people against bioterrorism. The purposeful release of viruses, bacteria, or other organisms to cause sickness or death is referred to as a bioterrorism.
Biodefense Market Trends
During the analysis period, increasing technical breakthroughs will have a beneficial influence on the market growth. As a result of the rise in bioterrorism, prominent industry players have incorporated advancements to biothreat detection systems that aid in the effective identification of bacteria and viruses. The availability of technologically sophisticated biothreat detection technologies will safeguard the population's safety and security, boosting the market growth. However, low government R&D funding for creating vaccines against bioterrorism attacks in emerging and undeveloped nations may limit the growth of the biodefense market to some extent.
Biodefense Market Analysis
Based on product, the biodefense market is bifurcated into vaccines, and biothreat detection devices. Vaccines are further segmented into botulism, smallpox, anthrax, and others. Whereas biothreat detection devices are further segmented into detectors/triggering devices, samplers, assays, reagents, and identifiers. Among these the vaccines segment accounted for around 64.5% market share in 2021 owing to increasing vaccines production across the globe to prevent spread of various viruses.
Furthermore, researchers are currently investigating novel vaccine technologies, such as vector technology, in order to induce rapid protection against pathogen attack will spur the biodefense market growth. Recently developed vaccines had the ability to address a wide range of bioterrorism chemicals and can induce a long-lasting immune response after a single oral dose. Also, several countries have witnessed a surging Ebola virus, Zika and COVID-19 infections and therefore many companies are competing to develop vaccines.
North America biodefense market captured over 41.6% revenue share in 2021 and is poised to grow substantially during the forthcoming years owing to growing importance of biodefense and the rising threat of harmful biological materials. Furthermore, the U.S is one of the region's most developed biodefense marketplaces, with well-established vaccine production facilities.
Additionally, U.S. government implements several initiatives that helps them in strengthening security against bioterrorism attacks. Government plans several biodefense programs such as pandemic influenza and infectious disease program. Other factors such as growing adoption of technological advanced product coupled with rising awareness regarding biodefense among the individuals will spur the regional market forecasts.
Biodefense Market Share
Some of the key market players operating in the biodefense industry include
These market players are employing a variety of development strategies, including continual innovation and technological advancements, in order to maintain business rivalry in the biodefense market.
Some of the recent industry developments:
The biodefense market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2022 to 2028, for the following segments:
Click here to Buy Section of this Report
By Product
The above information is provided for the following regions and countries:
By Region
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →